Mindy G. Schuster, MD, MSCE
Penn Medicine Provider
About me
- Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
My education and training
- Medical School: Yale University School of Medicine
- Residency: NewYork-Presbyterian/Weill Cornell Medical Center
- Fellowship: University of Pennsylvania Health System
Spoken languages
English
English
Insurance accepted
Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Infectious Disease, 1992
- American College of Physicians, National
- Infectious Disease Society of America, National
- Organ Transplant Infection Detection Project--Centers for Disease Control and Prevention (TRANSNET), National
- The College of Physicians of Philadelphia, National
Treatments and conditions
Research
Publications
Albaloul, H, Nemer, A, Saini N, Schuster MG Infectious Diseases:What you may have missed in 2025 , Annals of Internal Medicine, supplement ; 14 April 2026: 2026
Hamed HK, Nachman A, Riopel N, Schuster M. Infectious Disease, What you might have missed in 2024. , Annals of Internal Medicine, 178: 2025,S54-74
Baden LR, Swaminathan S, Almyroudis NG, Angarone M, Baluch L, Barros N, Bruss B, Cohen S, Cooper B, Chiang AD, Boghdadly ZE, Gregg K, Hakim H, Ho D, Khawaja F, Lee R, Lee F, Logan C, Manley K, Multani A, Pande A, Pergam S, Pisano J, Saullo J, Schuster M, et al. Prevention and treatment of cancer-related infections: National Comprehensive Cancer Network Clinical practice guidelines in oncology. Nov 2024, vol 22 (9). , National Comprehensive Cancer Network Clinical practice guidelines in oncology. , 22(9): 2024
Young JH, Ardura MI, Arrieta A, Bow EJ, Chandrasekar PH, Chen SC, Hammond SP, Husain S, Koo S, Laveren V, Nguyen MH, Patterson TF, So M, Thompson GR, Morrissey O, Schuster MG Modeling Invasive Aspergillosis Risk for the Application of ProphylaxisStrategies , Open Forum Infectious Disease, in press: 2024
Ohaly RA, Benoit ME, Schuster MG Infectious Diseases: What you may have missed in 2022 , Annals of Internal Medicine , 176(5): 2023,701-717
Freyer CW, Carulli A, Gier S, Ganetsky A, Timlin C, Schuster M, et al Letermovir vs high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical of mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide , Leukemia and Lymphoma: 2022
Minehart JC, Catania C, Perry L, Martin ME, Smith J, McCurdy SR, Pratz KW, Luger SM, Timlin C, Perl AE, Schuster M et al. Incidence and predictors of Sars-Cov-2 antibody responses following COVID-19 vaccination in allogeneic stem cell transplant recipients. , Blood 138 (S1)2888. 2021, 138: 2021,2888
Kim GYG, Burns J, Freyer CW, Hamilton KW, Frey NV, Gill SI, Hexner EO, Luger SM, Mangan JK, Martin ME, McCurdy SR, Perl AE, Porter DL, Schuster MG4 Stadtmauer EA5 Loren AW. Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents. , American Journal of Hematology: 2020
Schneeweiss S, Carver PL, Datta K, Galar A, Johnson MD, Letourneau AR, Marty F, Nagel J, Najdzinowicz M, Saul M, Schuster M, Shohan S, Silveira F, Varughese C, Wilck M, Weatherby L, Van Oene J, Walker AM Long-term risk of hepatocellular carcinoma mortality in 23,220 hospitalized patients treated with micafungin or other parenteral antifungals , J Antimicrob Chemother : 2019,pii: dkz39
Ganetsky A, Han, JH, Hughes ME, Babushok DV Frey NV, Gill SI, Hexner EO, Loren AW, Luger SM, Magan JM, Martin ME, Smith J, Freyer CW, Gilmar C, Schuster M, Stadtmauer EA, Porter DL Oral vancomycin prophylaxis is highly effective in preventing Clostridium difficile infection in allogeneic hematopoietic cell transplant recipients , Clin Infect Dis, 68(12): 2019,2003-2009